innoscripta SE (ISIN: DE000A40QVM8) is expanding into the United Kingdom, following its successful market entry into France earlier this year. The company has established a dedicated local sales team and has already secured its first UK customer: a software company with annual revenues in the mid-double-digit million euro range has chosen innoscripta's SaaS platform Clusterix to support its R&D tax relief claims.
Clusterix, which has been fully adapted to UK regulatory requirements, enables companies to systematically capture R&D projects, working hours, and eligible costs while creating a comprehensive, audit-ready documentation trail. This capability is increasingly important as HM Revenue & Customs (HMRC) has substantially tightened its documentation and compliance requirements for R&D tax relief claims in recent years.
The United Kingdom is Europe's second-largest R&D tax incentive market after France, with annual R&D tax reliefs of approximately EUR 8.7 billion (around 0.3% of GDP). This represents a market roughly seven times larger than Germany. innoscripta plans to significantly expand both its UK sales organization and customer base by the end of the year, with several additional customer engagements currently at an advanced stage of negotiations.
The expansion into the UK underscores innoscripta's commitment to international growth and its focus on helping companies navigate complex R&D tax relief processes. By digitizing and streamlining R&D documentation, Clusterix aims to reduce the risk of non-compliance and maximize eligible claims for businesses.
For more information about innoscripta and its Clusterix platform, visit the original release on NewMediaWire.
